Bullous pemphigoid in an infant using complementary medicine

Clinical and Experimental Dermatology

Volumn 34, Issue 2, 2009, Pages 195-198

  Purvis, D J ^a   Bhogal, B S ^b   Harper, J I ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC PHOSPHATE; MAGNESIUM DERIVATIVE; MAGNESIUM PHOSPHATE; POTASSIUM CHLORIDE; POTASSIUM DERIVATIVE; POTASSIUM SULFATE; PREDNISOLONE; SILVER; UNCLASSIFIED DRUG; YOUR HEALTHY FUTURE NUTRITION COLLOIDAL SILVER;

ALTERNATIVE MEDICINE; ARTICLE; BULLOUS PEMPHIGOID; CASE REPORT; CLINICAL FEATURE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; INFANT; MALE; PRIORITY JOURNAL; SKIN BIOPSY; TREATMENT DURATION;

ADRENAL CORTEX HORMONES; COMPLEMENTARY THERAPIES; DRUG INTERACTIONS; HUMANS; INFANT; MALE; PEMPHIGOID, BULLOUS; SILVER COMPOUNDS; SKIN; TREATMENT OUTCOME;

EID: 58549112186     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2008.02815.x     Document Type: Article

References (10)

1. Fisler RE, Saeb M, Liang MG et al. Childhood bullous pemphigoid: a clinicopathologic study and review of the literature. Am J Dermatopathol 2003 25 : 183 9.
2. Nemeth AJ, Klein AD, Gould EW, Schachner LA. Childhood bullous pemphigoid. Clinical and immunologic features, treatment, and prognosis. Arch Dermatol 1991 127 : 378 86.
3. Vassileva S. Drug-induced pemphigoid: bullous and cicatricial. Clin Dermatol 1998 16 : 379 87.
4. Walsh SR, Hogg D, Mydlarski PR. Bullous pemphigoid: from bench to bedside. Drugs 2005 65 : 905 26.
5. Cincotta DR, Crawford NW, Lim A et al. Comparison of complementary and alternative medicine use: reasons and motivations between two tertiary children's hospitals. Arch Dis Child 2006 91 : 153 8.
6. Petronius D, Bergman R. Bullous pemphigoid in two young infants. Pediatr Dermatol 2002 19 : 119 21.
7. Kuenzli S, Grimaitre M, Krischer J et al. Childhood bullous pemphigoid: report of a case with life-threatening course during homeopathy treatment. Pediatr Dermatol 2004 21 : 160 3.
8. Fung MC, Weintraub M, Bowen DL. Colloidal silver proteins marketed as health supplements. JAMA 1995 274 : 1196 7.
9. US Food and Drugs Administration. FDA issues final rule on OTC drug products containing colloidal silver. Available at: http://www.fda.gov/bbs/ topics/ANSWERS/ANS00971.html, 1999 (accessed 29 October 2007).
10. Wadhera A, Fung M. Systemic argyria associated with ingestion of colloidal silver. Dermatol Online J 2005 11 : 12.